| For: | Kourie HR, Tabchi S, Ghosn M. Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality. World J Gastroenterol 2017; 23(17): 3017-3021 [PMID: 28533658 DOI: 10.3748/wjg.v23.i17.3017] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i17/3017.htm |
| Number | Citing Articles |
| 1 |
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar, Vanesa Bernal Monterde. Efectos adversos inmunomediados gastrointestinales y hepáticos inducidos por los inhibidores del punto de control inmunitario: estudio descriptivo observacional. Gastroenterología y Hepatología 2021; 44(4) doi: 10.1016/j.gastrohep.2020.07.009
|
| 2 |
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar, Vanesa Bernal Monterde. Gastrointestinal and liver immune-related adverse effects induced by immune checkpoint inhibitors: A descriptive observational study. Gastroenterología y Hepatología (English Edition) 2021; 44(4) doi: 10.1016/j.gastre.2020.07.007
|
| 3 |
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
|
| 4 |
Young Kwang Chae, Eliana Dietrich, Sandip P. Patel, Mark Zalupski, Anup Kasi, Maged Khalil, Aparna Kalyan, Blase Polite, Sarah Fenton, Liam IL-Young Chung, Christine M. McLeod, Helen X. Chen, Elad Sharon, Sara Threlkel, Megan Othus, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock. A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the small bowel tumor cohort. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359261458742
|
| 5 |
Yu-Han Wei, Shun-Chao Zhang, Bing-Jie Guan, Jia-Ning Jian, Chun-Guang Li, Ze-Kun Wang, Hao-Ran Qu, Zhi-Gang Li, Meng-Ya Liu, Jun-Tao Wang. Research advances in targeting claudin 18.2 in pancreatic ductal adenocarcinoma treatment. World Journal of Gastroenterology 2026; 32(45): 122906 doi: 10.3748/wjg.122906
|
| 6 |
Victor Hugo Fonseca de Jesus, Tiago Cordeiro Felismino, Milton José de Barros e Silva, Virgílio de Souza e Silva, Rachel P Riechelmann. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies. Clinics 2018; 73 doi: 10.6061/clinics/2018/e510s
|
| 7 |
Guanghua Zhang, Jing Pan, Changyuan Xing. Computer-aided diagnosis of digestive tract tumor based on deep learning for medical images. Network Modeling Analysis in Health Informatics and Bioinformatics 2022; 11(1) doi: 10.1007/s13721-021-00343-1
|
| 8 |
Nina Bratanič, Jernej Kovač, Katka Pohar, Katarina Trebušak Podkrajšek, Alojz Ihan, Tadej Battelino, Magdalena Avbelj Stefanija. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency. Orphanet Journal of Rare Diseases 2017; 12(1) doi: 10.1186/s13023-017-0682-5
|
| 9 |
George Denis Alexandru Popescu, Cristian Scheau, Ioana Anca Badarau, Mihai-Daniel Dumitrache, Ana Caruntu, Andreea-Elena Scheau, Daniel Octavian Costache, Raluca Simona Costache, Carolina Constantin, Monica Neagu, Constantin Caruntu. The Effects of Capsaicin on Gastrointestinal Cancers. Molecules 2020; 26(1) doi: 10.3390/molecules26010094
|
| 10 |
Kaitlyn D LaCourse, Christopher D Johnston, Susan Bullman. The relationship between gastrointestinal cancers and the microbiota. The Lancet Gastroenterology & Hepatology 2021; 6(6) doi: 10.1016/S2468-1253(20)30362-9
|
| 11 |
Javeria Naz, Muhammad Imran Sharif, Muhammad Irfan Sharif, Seifedine Kadry, Hafiz Tayyab Rauf, Adham E. Ragab. A Comparative Analysis of Optimization Algorithms for Gastrointestinal Abnormalities Recognition and Classification Based on Ensemble XcepNet23 and ResNet18 Features. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061723
|